Johnston, IA, United States of America

Stephen Lawrence Gasior

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):

Title: The Innovations of Stephen Lawrence Gasior

Introduction

Stephen Lawrence Gasior is an accomplished inventor based in Johnston, IA (US). He has made significant contributions to the field of gene editing, holding a total of 2 patents. His work focuses on the use of morphogenic factors to enhance the effectiveness of gene editing techniques.

Latest Patents

Gasior's latest patents revolve around the use of morphogenic factors for the improvement of double-strand-break-inducing agent activity in eukaryotic cells. The methods and compositions he developed allow for the enhancement of gene editing through the application of one or more morphogenic factors or developmental genes. These factors can be introduced to the same cell or a different cell than the one receiving the double-strand-break-inducing agent. The morphogenic factor may be delivered as a polynucleotide composition on a recombinant vector, positioned outside of a T-DNA border. Additionally, the morphogenic factor can be introduced via the upregulation of an endogenous gene, and may include a cell-penetrating peptide. Furthermore, the morphogenic factor can be co-introduced with a vector comprising RepA.

Career Highlights

Gasior is currently employed at Pioneer Hi-Bred International, Inc., where he continues to innovate in the field of biotechnology. His work has been instrumental in advancing gene editing methodologies, making significant strides in the application of morphogenic factors.

Collaborations

Throughout his career, Gasior has collaborated with notable colleagues, including William James Gordon-Kamm and Keith S. Lowe. These partnerships have contributed to the development of groundbreaking technologies in gene editing.

Conclusion

Stephen Lawrence Gasior's contributions to the field of gene editing through his innovative patents and collaborations highlight his role as a leading inventor in biotechnology. His work continues to pave the way for advancements in genetic research and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…